Rhode Island Multistate Pharmacy Jurisprudence (MPJE) Practice Exam

Medium risk CSPs must meet which of the following criteria?

1. Single-volume transfer compounding

2. Low risk conditions plus multiple doses or long duration

3. No sterilization required

4. Only one patient per preparation

The correct answer is: Low risk conditions plus multiple doses or long duration

Medium-risk compounding sterile preparations (CSPs) involves specific criteria that distinguish them from low and high-risk CSPs. The defining characteristic of medium-risk CSPs is that they are created under low-risk conditions but involve multiple doses or are compounded for a prolonged duration. This means that they may require compounding from multiple sterile products, which increases the complexity and potential risk of contamination compared to a simple low-risk preparation. The complexity of medium-risk CSPs often necessitates more stringent handling and storage guidelines, as they may be intended for administration over a longer period or could be made in quantities that exceed the immediate needs of patients. Therefore, the criteria linking medium-risk CSPs to low-risk conditions along with the potential for multiple doses or extended stability periods is critical for ensuring patient safety in a pharmacy practice setting. Other options, while related to compounding practices, do not encapsulate the specific requirements for categorizing CSPs as medium risk. For instance, single-volume transfer compounding (option A) aligns more with low-risk CSPs. Options such as the sterilization requirement (option C) can be relevant in the context of all risk categories, and limiting preparations to one patient per preparation (option D) would apply to various CSPs but does